High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Brassica juncea that contains high amounts of selenium may slow the growth of
cancer cells. Drugs used in chemotherapy, such as irinotecan and capecitabine, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Giving high-selenium Brassica juncea together with combination
chemotherapy may kill more cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of high-selenium
Brassica juncea and capecitabine when given together with irinotecan in treating patients
with advanced cancer.